Actinium Pharmaceuticals Inc (ATNM)
8.96
+0.21
(+2.40%)
USD |
NYAM |
May 03, 16:00
8.915
-0.04
(-0.50%)
After-Hours: 20:00
Actinium Pharmaceuticals Shares Outstanding: 29.78M for April 26, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 26, 2024 | 29.78M |
March 31, 2024 | 29.40M |
March 27, 2024 | 29.40M |
January 30, 2024 | 27.76M |
December 31, 2023 | 27.63M |
November 01, 2023 | 27.41M |
October 30, 2023 | 27.41M |
September 30, 2023 | 27.41M |
August 14, 2023 | 27.00M |
August 07, 2023 | 27.00M |
June 30, 2023 | 26.98M |
May 15, 2023 | 26.41M |
March 31, 2023 | 25.73M |
December 31, 2022 | 25.67M |
November 14, 2022 | 25.48M |
November 11, 2022 | 25.48M |
September 30, 2022 | 25.21M |
August 12, 2022 | 25.18M |
June 30, 2022 | 24.87M |
May 13, 2022 | 23.78M |
March 31, 2022 | 22.14M |
March 25, 2022 | 22.14M |
December 31, 2021 | 22.14M |
November 12, 2021 | 22.03M |
September 30, 2021 | 22.03M |
Date | Value |
---|---|
September 13, 2021 | 22.02M |
July 28, 2021 | 21.33M |
June 30, 2021 | 21.09M |
May 14, 2021 | 20.19M |
March 31, 2021 | 19.25M |
March 26, 2021 | 18.77M |
December 31, 2020 | 17.53M |
October 23, 2020 | 13.59M |
September 30, 2020 | 13.59M |
September 29, 2020 | 13.59M |
August 13, 2020 | 13.59M |
August 11, 2020 | 13.59M |
August 05, 2020 | 13.59M |
June 30, 2020 | 13.17M |
June 29, 2020 | 13.17M |
June 19, 2020 | 13.17M |
June 11, 2020 | 11.32M |
June 01, 2020 | 10.12M |
May 07, 2020 | 10.11M |
May 01, 2020 | 10.11M |
April 24, 2020 | 10.11M |
April 20, 2020 | 5.834M |
April 14, 2020 | 5.828M |
March 31, 2020 | 5.828M |
December 31, 2019 | 5.49M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
5.401M
Minimum
May 09 2019
29.78M
Maximum
Apr 26 2024
18.11M
Average
20.64M
Median
Shares Outstanding Benchmarks
Perspective Therapeutics Inc | 586.92M |
Eli Lilly and Co | 950.41M |
Cellectar Biosciences Inc | 32.26M |
Outlook Therapeutics Inc | 21.58M |
Bristol-Myers Squibb Co | 2.027B |